Literature DB >> 26629312

Regulation of MYC gene expression by aberrant Wnt/β-catenin signaling in colorectal cancer.

Sherri Rennoll1, Gregory Yochum1.   

Abstract

The Wnt/β-catenin signaling pathway controls intestinal homeostasis and mutations in components of this pathway are prevalent in human colorectal cancers (CRCs). These mutations lead to inappropriate expression of genes controlled by Wnt responsive DNA elements (WREs). T-cell factor/Lymphoid enhancer factor transcription factors bind WREs and recruit the β-catenin transcriptional co-activator to activate target gene expression. Deregulated expression of the c-MYC proto-oncogene (MYC) by aberrant Wnt/β-catenin signaling drives colorectal carcinogenesis. In this review, we discuss the current literature pertaining to the identification and characterization of WREs that control oncogenic MYC expression in CRCs. A common theme has emerged whereby these WREs often map distally to the MYC genomic locus and control MYC gene expression through long-range chromatin loops with the MYC proximal promoter. We propose that by determining which of these WREs is critical for CRC pathogenesis, novel strategies can be developed to treat individuals suffering from this disease.

Entities:  

Keywords:  Chromatin looping; MYC; Wnt; Wnt responsive DNA element; β-catenin

Year:  2015        PMID: 26629312      PMCID: PMC4657124          DOI: 10.4331/wjbc.v6.i4.290

Source DB:  PubMed          Journal:  World J Biol Chem        ISSN: 1949-8454


  88 in total

Review 1.  Transcriptional regulation and transformation by Myc proteins.

Authors:  Sovana Adhikary; Martin Eilers
Journal:  Nat Rev Mol Cell Biol       Date:  2005-08       Impact factor: 94.444

2.  The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling.

Authors:  Sari Tuupanen; Mikko Turunen; Rainer Lehtonen; Outi Hallikas; Sakari Vanharanta; Teemu Kivioja; Mikael Björklund; Gonghong Wei; Jian Yan; Iina Niittymäki; Jukka-Pekka Mecklin; Heikki Järvinen; Ari Ristimäki; Mariachiara Di-Bernardo; Phil East; Luis Carvajal-Carmona; Richard S Houlston; Ian Tomlinson; Kimmo Palin; Esko Ukkonen; Auli Karhu; Jussi Taipale; Lauri A Aaltonen
Journal:  Nat Genet       Date:  2009-06-28       Impact factor: 38.330

3.  Super-enhancers in the control of cell identity and disease.

Authors:  Denes Hnisz; Brian J Abraham; Tong Ihn Lee; Ashley Lau; Violaine Saint-André; Alla A Sigova; Heather A Hoke; Richard A Young
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

4.  Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24.

Authors:  Julius Gudmundsson; Patrick Sulem; Andrei Manolescu; Laufey T Amundadottir; Daniel Gudbjartsson; Agnar Helgason; Thorunn Rafnar; Jon T Bergthorsson; Bjarni A Agnarsson; Adam Baker; Asgeir Sigurdsson; Kristrun R Benediktsdottir; Margret Jakobsdottir; Jianfeng Xu; Thorarinn Blondal; Jelena Kostic; Jielin Sun; Shyamali Ghosh; Simon N Stacey; Magali Mouy; Jona Saemundsdottir; Valgerdur M Backman; Kristleifur Kristjansson; Alejandro Tres; Alan W Partin; Marjo T Albers-Akkers; Javier Godino-Ivan Marcos; Patrick C Walsh; Dorine W Swinkels; Sebastian Navarrete; Sarah D Isaacs; Katja K Aben; Theresa Graif; John Cashy; Manuel Ruiz-Echarri; Kathleen E Wiley; Brian K Suarez; J Alfred Witjes; Mike Frigge; Carole Ober; Eirikur Jonsson; Gudmundur V Einarsson; Jose I Mayordomo; Lambertus A Kiemeney; William B Isaacs; William J Catalona; Rosa B Barkardottir; Jeffrey R Gulcher; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2007-04-01       Impact factor: 38.330

5.  Identification of two enhancer elements downstream of the human c-myc gene.

Authors:  J Mautner; S Joos; T Werner; D Eick; G W Bornkamm; A Polack
Journal:  Nucleic Acids Res       Date:  1995-01-11       Impact factor: 16.971

6.  Selective inhibition of tumor oncogenes by disruption of super-enhancers.

Authors:  Jakob Lovén; Heather A Hoke; Charles Y Lin; Ashley Lau; David A Orlando; Christopher R Vakoc; James E Bradner; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2013-04-11       Impact factor: 41.582

Review 7.  Caught up in a Wnt storm: Wnt signaling in cancer.

Authors:  Rachel H Giles; Johan H van Es; Hans Clevers
Journal:  Biochim Biophys Acta       Date:  2003-06-05

8.  A common genetic risk factor for colorectal and prostate cancer.

Authors:  Christopher A Haiman; Loïc Le Marchand; Jennifer Yamamato; Daniel O Stram; Xin Sheng; Laurence N Kolonel; Anna H Wu; David Reich; Brian E Henderson
Journal:  Nat Genet       Date:  2007-07-08       Impact factor: 38.330

9.  Identification of {beta}-catenin binding regions in colon cancer cells using ChIP-Seq.

Authors:  Daniel Bottomly; Sydney L Kyler; Shannon K McWeeney; Gregory S Yochum
Journal:  Nucleic Acids Res       Date:  2010-05-11       Impact factor: 16.971

Review 10.  MYC-y mice: from tumour initiation to therapeutic targeting of endogenous MYC.

Authors:  Jennifer P Morton; Owen J Sansom
Journal:  Mol Oncol       Date:  2013-03-08       Impact factor: 6.603

View more
  53 in total

1.  The iron chelator Dp44mT suppresses osteosarcoma's proliferation, invasion and migration: in vitro and in vivo.

Authors:  Pengcheng Li; Xun Zheng; Kangquan Shou; Yahui Niu; Chao Jian; Yong Zhao; Wanrong Yi; Xiang Hu; Aixi Yu
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

2.  The Covalent CDK7 Inhibitor THZ1 Potently Induces Apoptosis in Multiple Myeloma Cells In Vitro and In Vivo.

Authors:  Yu Zhang; Liang Zhou; Dipankar Bandyopadhyay; Kanika Sharma; Alexander Joseph Allen; Maciej Kmieciak; Steven Grant
Journal:  Clin Cancer Res       Date:  2019-07-29       Impact factor: 12.531

3.  Colorectal cancer susceptibility loci as predictive markers of rectal cancer prognosis after surgery.

Authors:  Yue Hu; Jochen Gaedcke; Georg Emons; Tim Beissbarth; Marian Grade; Peter Jo; Meredith Yeager; Stephen J Chanock; Hendrik Wolff; Jordi Camps; B Michael Ghadimi; Thomas Ried
Journal:  Genes Chromosomes Cancer       Date:  2017-11-28       Impact factor: 5.006

4.  WNT signaling and AHCTF1 promote oncogenic MYC expression through super-enhancer-mediated gene gating.

Authors:  Barbara A Scholz; Noriyuki Sumida; Anita Göndör; Rolf Ohlsson; Carolina Diettrich Mallet de Lima; Ilyas Chachoua; Mirco Martino; Ilias Tzelepis; Andrej Nikoshkov; Honglei Zhao; Rashid Mehmood; Emmanouil G Sifakis; Deeksha Bhartiya
Journal:  Nat Genet       Date:  2019-11-29       Impact factor: 38.330

Review 5.  Neural crest and cancer: Divergent travelers on similar paths.

Authors:  Kristin L Gallik; Randall W Treffy; Lynne M Nacke; Kamil Ahsan; Manuel Rocha; Abigail Green-Saxena; Ankur Saxena
Journal:  Mech Dev       Date:  2017-09-06       Impact factor: 1.882

Review 6.  Inhibition of nuclear Wnt signalling: challenges of an elusive target for cancer therapy.

Authors:  Yung Lyou; Amber N Habowski; George T Chen; Marian L Waterman
Journal:  Br J Pharmacol       Date:  2017-08-24       Impact factor: 8.739

Review 7.  Profiling Colorectal Cancer in the Landscape Personalized Testing-Advantages of Liquid Biopsy.

Authors:  Donatella Verbanac; Andrea Čeri; Iva Hlapčić; Mehdi Shakibaei; Aranka Brockmueller; Božo Krušlin; Neven Ljubičić; Neven Baršić; Dijana Detel; Lara Batičić; Lada Rumora; Anita Somborac-Bačura; Mario Štefanović; Ivana Ćelap; Alma Demirović; Roberta Petlevski; József Petrik; Marija Grdić Rajković; Andrea Hulina-Tomašković; Ivana Rako; Luciano Saso; Karmela Barišić
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

8.  PIK3C3 Inhibition Promotes Sensitivity to Colon Cancer Therapy by Inhibiting Cancer Stem Cells.

Authors:  Balawant Kumar; Rizwan Ahmad; Swagat Sharma; Saiprasad Gowrikumar; Mark Primeaux; Sandeep Rana; Amarnath Natarajan; David Oupicky; Corey R Hopkins; Punita Dhawan; Amar B Singh
Journal:  Cancers (Basel)       Date:  2021-04-30       Impact factor: 6.639

9.  Urokinase-type plasminogen activator-mediated crosstalk between N-cadherin and β-catenin promotes wound healing.

Authors:  Ariel Diaz; Cynthia Martin-Jimenez; Yang Xu; Paola Merino; Yena Woo; Enrique Torre; Manuel Yepes
Journal:  J Cell Sci       Date:  2021-06-04       Impact factor: 5.235

10.  5-aza-2'-deoxycitidine inhibits cell proliferation, extracellular matrix formation and Wnt/β-catenin pathway in human uterine leiomyomas.

Authors:  Irene Cervelló; Hortensia Ferrero; María Cristina Carbajo-García; Ana Corachán; Marina Segura-Benitez; Javier Monleón; Julia Escrig; Amparo Faus; Antonio Pellicer
Journal:  Reprod Biol Endocrinol       Date:  2021-07-08       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.